SIRT1 and non-small cell lung carcinoma: A recent report showed that Sirt1 expression was a strong predictor for poor prognosis in NSCLC patients underwent platinum-based chemotherapy, and interfering with Sirt1 expression significantly enhanced the chemosensitivity to cisplatin treatment (Zhang et al., 2013).